Further studies are necessary to establish consistent and reliable protocols for PD-L1 testing, incorporating advanced techniques and comprehensive analyses to refine its prognostic and predictive capabilities in clinical practice, particularly for patients with sarcomas. The gene discussed is CD274; the disease is sarcoma.